Beltrame Anna, Barabino Gianfranco, Wei Yiran, Clapasson Andrea, Orza Pierantonio, Perandin Francesca, Piubelli Chiara, Monteiro Geraldo Badona, Longoni Silvia Stefania, Rodari Paola, Duranti Silvia, Silva Ronaldo, Fittipaldo Veronica Andrea, Bisoffi Zeno
Department of Infectious, Tropical Diseases and Microbiology, I.R.C.C.S. Sacro Cuore Don Calabria Hospital, Via Sempreboni 5, 37024 Negrar di Valpolicella, Italy.
Dermatological Clinic, National Reference Center for Hansen's Disease, Ospedale Policlinico San Martino, Sistema Sanitario Regione Liguria, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Largo Rosanna Benzi 10, 16132 Genoa, Italy.
Microorganisms. 2020 Jul 24;8(8):1113. doi: 10.3390/microorganisms8081113.
Leprosy is a chronic neglected infectious disease that affects over 200,000 people each year and causes disabilities in more than four million people in Asia, Africa, and Latin America. The disease can appear with a wide spectrum of clinical forms, and therefore the clinical suspicion is often difficult. Refugees and migrants from endemic countries affected by leprosy can remain undiagnosed in Europe due to the unpreparedness of clinicians. We retrospectively describe the characteristics of 55 refugees/migrants with a diagnosis of leprosy established in Italy from 2009 to 2018. Continents of origin were Africa (42%), Asia (40%), and South and Central America (18%). The symptoms reported were skin lesions (91%), neuropathy (71%), edema (7%), eye involvement (6%), fever (6%), arthritis (4%), and lymphadenopathy (4%). Seven patients (13%) had irreversible complications. Overall, 35% were relapses and 66% multibacillary leprosy. Furthermore, we conducted a review of 17 case reports or case series and five nationwide reports, published in the same decade, describing 280 migrant patients with leprosy in Europe. In Europe, leprosy is a rare chronic infectious disease, but it has not completely disappeared. Diagnosis and treatment of leprosy in refugees and migrants from endemic countries are a challenge. European guidelines for this neglected disease in this high-risk population would be beneficial.
麻风病是一种长期被忽视的慢性传染病,每年影响超过20万人,并导致亚洲、非洲和拉丁美洲400多万人残疾。该疾病可呈现多种临床症状,因此临床诊断往往具有难度。由于临床医生准备不足,来自麻风病流行国家的难民和移民在欧洲可能仍未得到诊断。我们回顾性描述了2009年至2018年在意大利确诊为麻风病的55名难民/移民的特征。其原籍洲分别为非洲(42%)、亚洲(40%)以及南美洲和中美洲(18%)。报告的症状有皮肤病变(91%)、神经病变(71%)、水肿(7%)、眼部受累(6%)、发热(6%)、关节炎(4%)和淋巴结病(4%)。7名患者(13%)出现了不可逆的并发症。总体而言,35%为复发患者,66%为多菌型麻风病患者。此外,我们还查阅了同一十年间发表的17篇病例报告或病例系列以及5篇全国性报告,这些报告描述了欧洲280名患麻风病的移民患者。在欧洲,麻风病是一种罕见的慢性传染病,但尚未完全消失。对来自流行国家的难民和移民进行麻风病的诊断和治疗是一项挑战。针对这一高风险人群制定欧洲关于这种被忽视疾病的指南将大有裨益。